US Patent 7507580 Ztnfr14, a tumor necrosis factor receptor
Patent 7507580 was granted and assigned to ZymoGenetics on March, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+453 characters)
Article
Patent abstract
Novel tumor necrosis factor receptor (TNFR) polypeptides, polynucleotides encoding the polypeptides, antibodies and related compositions and methods are disclosed. The polypeptides may be used for detecting ligand, as well as agonists and antagonists. The polypeptides, polynucleotides and antibodies may also be used in methods that modulate tumor growth, metastasis, and immunity such as separating resting from stimulated immune cells.
Edits on 6 Aug, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
75075800
Date of Patent
March 24, 2009
0Patent Application Number
109675270
Date Filed
October 18, 2004
0Patent Primary Examiner
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07507580 Ztnfr14, a tumor necrosis factor receptor US Patent 7507580 Ztnfr14, a tumor necrosis factor receptor
Infobox
Patent Number
0750758000
Patent Number
750758000
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075075800
Date of Patent
March 24, 2009
0Patent Application Number
109675270
Date Filed
October 18, 2004
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075075800
Date of Patent
March 24, 2009
0Patent Application Number
109675270
Date Filed
October 18, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07507580 Ztnfr14, a tumor necrosis factor receptor
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07507580
Date of patent
March 24, 2009
Patent application number
10967527
Date Filed
October 18, 2004
Patent primary examiner
Find more entities like US Patent 7507580 Ztnfr14, a tumor necrosis factor receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.